Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
about
A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variantHarnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesCongenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 moduleIL-21 Signaling in ImmunitySevere infectious diseases of childhood as monogenic inborn errors of immunityInterleukin 17-Mediated Host Defense against Candida albicansIL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansInborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypesSTAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertaintiesThe regulation of inflammation by interferons and their STATsInterleukin-27: balancing protective and pathological immunityPrimary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestationsIL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A TherapiesIL-17 family: cytokines, receptors and signalingProtein tyrosine phosphatases as wardens of STAT signalingMendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunityPopulation genetic tools for dissecting innate immunity in humansDiscovery of single-gene inborn errors of immunity by next generation sequencingMucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapyMendelian genetics of human susceptibility to fungal infectionThe environment-pathogen-host axis in communicable and non-communicable diseases: recent advances in experimental and clinical researchInducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivoThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testingMechanisms underlying helper T-cell plasticity: implications for immune-mediated disease.Unbalanced Immune System: Immunodeficiencies and AutoimmunityFlow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary ImmunodeficienciesHuman TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndromeIL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasisFifty-five-year-old man with chronic yeast infections.Computational approaches for discovery of common immunomodulators in fungal infections: towards broad-spectrum immunotherapeutic interventions.A unified test of linkage analysis and rare-variant association for analysis of pedigree sequence data.A Novel Heterozygous Mutation in the STAT1 SH2 Domain Causes Chronic Mucocutaneous Candidiasis, Atypically Diverse Infections, Autoimmunity, and Impaired Cytokine RegulationA 3-Year-Old Girl with Recurrent Infections and Autoimmunity due to a STAT1 Gain-of-Function Mutation: The Expanding Clinical Presentation of Primary ImmunodeficienciesHyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalitiesTherapeutic modulators of STAT signalling for human diseasesSkin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses.Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.Induction and activation of human Th17 by targeting antigens to dendritic cells via dectin-1.Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.Cellular and Molecular Defects Underlying Invasive Fungal Infections-Revelations from Endemic Mycoses.
P2860
Q21090962-F32B2285-3C95-4264-8273-D4FFF188D157Q21131160-ECE35538-7995-4625-BE8A-39117E8C96C5Q24318764-40A4DD41-40BF-40BA-8274-A5F250723820Q26766361-4587AC55-85AC-42AB-888A-CC0AF2DC3D44Q26775891-74E3EB7D-C2FB-41FC-B758-1EEC140839CBQ26798127-23C424A9-CB9F-4E45-9E65-466D5C340033Q26799351-AFBA710C-257C-4DFE-BBF5-FDFE1F494092Q26825342-8FB5A6CC-6AC2-4F28-999B-564B08BEBCA6Q26829298-05536E46-AE9D-444E-A008-CE969A271554Q26829387-5E624433-A8FC-4531-BFBF-18C4CA99BEE9Q26830400-8355998D-1858-4BA9-9B14-C3FA500C5EADQ26830870-B5DEA549-8707-432E-B155-B98DE51A18E0Q26830943-38133A19-738D-4161-AF9A-FE017B98AAB3Q26860251-15DD7BC6-0905-4F9A-85AD-4DC427BA2914Q26861574-CB0C6D5E-DA0E-4409-9F02-38A54FB26717Q26862947-17CD55DC-AC84-4749-9C87-C58C97C8AD52Q27001032-D252C502-23F4-4123-B06A-9E9CBEB6E213Q27003187-476C4926-48FE-4267-ABE1-007B66AD5A88Q27010562-94CDA322-C4FE-4A89-84C7-909004641E52Q27022250-E80C5519-AFBC-4A1E-96A1-A68C13838891Q27026740-61443B19-36CF-4389-9077-92E7C5CB7481Q27330038-FB469A1E-D14E-4514-A3D3-742B32AF89C5Q27687800-3D0C1ED9-81F7-4236-9B3B-064D5D74DD09Q27687830-EB719B65-5C1C-4986-BE82-6B0528BAC978Q28075911-697CC45B-31F0-4929-A834-93739E56DCE8Q28076919-8E8EBB5F-DEF5-4F74-90D4-0D779ECAEB2FQ28266613-E8C959E4-5698-4744-AE68-43030A9F80DEQ28534626-D8DF6BC6-E57E-45C7-B374-50364D1E5945Q30410910-D4266E4B-C606-4E94-8A8F-482FAA00D45FQ30558805-BAF8B2EE-2E01-4320-B773-CE23FE1440E3Q30823228-7307BF68-E743-4026-B93F-D56D2940BB4DQ30841541-F60056A6-64C7-4046-9B2C-2E197F38F721Q33440609-7BDA0C9F-C3CB-475C-AABD-A1C04DC82209Q33660776-76ED3BF1-E595-430D-99FA-266E8A871ED3Q33684732-E02EAB4F-0508-4507-B66A-6B986F8BAB17Q33709446-F36531A3-B6E1-429B-B922-2CAA4C6B843AQ33718865-60E825F5-2DEC-40F9-8B99-2B3881CC4241Q33723950-4072EECA-4398-47C1-8A7A-8B1BEC30387BQ33778939-EA17FF33-665E-4993-A6F9-EF9A88F7DD6EQ33843057-AC28C433-2DF1-4C8B-83D1-FBC17ADF7D61
P2860
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Gain-of-function human STAT1 m ...... nic mucocutaneous candidiasis.
@ast
Gain-of-function human STAT1 m ...... nic mucocutaneous candidiasis.
@en
type
label
Gain-of-function human STAT1 m ...... nic mucocutaneous candidiasis.
@ast
Gain-of-function human STAT1 m ...... nic mucocutaneous candidiasis.
@en
prefLabel
Gain-of-function human STAT1 m ...... nic mucocutaneous candidiasis.
@ast
Gain-of-function human STAT1 m ...... nic mucocutaneous candidiasis.
@en
P2093
P2860
P50
P356
P1476
Gain-of-function human STAT1 m ...... nic mucocutaneous candidiasis.
@en
P2093
Alexandra Y Kreins
Alexandre Bolze
Amos Etzioni
Annette F Jansson
Antoine Toulon
Avinash Abhyankar
Barbara Drexel
Beata Toth
Bernd Belohradsky
Carlos Torres Lozano
P2860
P304
P356
10.1084/JEM.20110958
P407
P50
P577
2011-07-04T00:00:00Z